Lisbon, Portugal – This Alzheimer’s disease and Parkinson’s disease Conference will present all the latest breakthroughs in treatment, translational R&D, early diagnosis, drug development and clinical trials in Alzheimer’s, Parkinson’s and other related neurological disorders.
The AD/PD™ Conference has grown to be one of the leading events in the field of neurodegenerative disorders with over 4,100 participants from 61 countries and over 2,000 abstracts in 2023.
The AD/PD™ Conference is where the brightest minds gather to explore the latest research, clinical trials, and treatments for Alzheimer’s and Parkinson’s. From uncovering groundbreaking discoveries to sharing the latest developments in treatments.
The meeting will give you the amazing opportunity to meet and hear what the leading international experts are working on, discuss the latest news and trends in the field, and present in front of them your own work and gain valuable feedback.
AD/PD™ focuses on basic science and translational and clinical research to bring you:
New insights on disease mechanisms and etiologies.
The latest findings from clinical trials.
Innovative outlooks on therapy and prevention.
Advances in diagnostic markers.
Successful strategies to enhance collaboration between academia and industry.
A great opportunity to interact with peers and experts in neurodegenerative diseases.
For further details about the congress, including registration, please click here.
Conference details
When: March 5-9 2024
Venue: Lisbon Congress Centre, Praça das Indústrias 1, 1300-307 Lisbon, Portugal